ELVN
Price
$24.40
Change
+$0.83 (+3.52%)
Updated
Dec 17, 04:59 PM (EDT)
85 days until earnings call
PMCB
Price
$1.65
Change
-$0.02 (-1.20%)
Updated
Dec 18, 10:30 AM (EDT)
Earnings call today
Ad is loading...

ELVN vs PMCB

Header iconELVN vs PMCB Comparison
Open Charts ELVN vs PMCBBanner chart's image
Enliven Therapeutics
Price$24.40
Change+$0.83 (+3.52%)
Volume$3.26K
CapitalizationN/A
PharmaCyte Biotech
Price$1.65
Change-$0.02 (-1.20%)
Volume$114
CapitalizationN/A
ELVN vs PMCB Comparison Chart
Loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMCB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. PMCB commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and PMCB is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ELVN: $24.39 vs. PMCB: $1.67)
Brand notoriety: ELVN and PMCB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 102% vs. PMCB: 13%
Market capitalization -- ELVN: $1.19B vs. PMCB: $11.64M
ELVN [@Biotechnology] is valued at $1.19B. PMCB’s [@Biotechnology] market capitalization is $11.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 0 FA rating(s) are green whilePMCB’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 0 green, 5 red.
  • PMCB’s FA Score: 1 green, 4 red.
According to our system of comparison, ELVN is a better buy in the long-term than PMCB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 6 TA indicator(s) are bullish while PMCB’s TA Score has 5 bullish TA indicator(s).

  • ELVN’s TA Score: 6 bullish, 4 bearish.
  • PMCB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than PMCB.

Price Growth

ELVN (@Biotechnology) experienced а +2.52% price change this week, while PMCB (@Biotechnology) price change was +3.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.42%, and the average quarterly price growth was +4.21%.

Reported Earning Dates

ELVN is expected to report earnings on Mar 13, 2025.

PMCB is expected to report earnings on Dec 18, 2024.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.19B) has a higher market cap than PMCB($11.6M). ELVN YTD gains are higher at: 76.228 vs. PMCB (-22.685). PMCB has higher annual earnings (EBITDA): -4.12M vs. ELVN (-100.07M). ELVN has more cash in the bank: 292M vs. PMCB (86.9M). PMCB has less debt than ELVN: PMCB (75.2K) vs ELVN (85K). ELVN (0) and PMCB (0) have equivalent revenues.
ELVNPMCBELVN / PMCB
Capitalization1.19B11.6M10,276%
EBITDA-100.07M-4.12M2,430%
Gain YTD76.228-22.685-336%
P/E RatioN/A1.90-
Revenue00-
Total Cash292M86.9M336%
Total Debt85K75.2K113%
FUNDAMENTALS RATINGS
PMCB: Fundamental Ratings
PMCB
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNPMCB
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMCB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VQSRX28.29N/A
N/A
Virtus KAR Small-Cap Value R6
TTDAX10.62-0.03
-0.28%
Toews Tactical Defensive Alpha
MVGIX16.79-0.07
-0.42%
MFS Low Volatility Global Equity I
USLIX85.87-0.46
-0.53%
JHancock U.S. Global Leaders Growth I
JDVPX25.97-0.21
-0.80%
JHancock Disciplined Value R2

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with OCEA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then OCEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+3.48%
OCEA - ELVN
48%
Loosely correlated
-2.34%
CRNX - ELVN
46%
Loosely correlated
+1.35%
BPMC - ELVN
39%
Loosely correlated
+1.14%
VYGR - ELVN
38%
Loosely correlated
-3.55%
ACLX - ELVN
38%
Loosely correlated
-1.67%
More

PMCB and

Correlation & Price change

A.I.dvisor tells us that PMCB and FATE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMCB and FATE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMCB
1D Price
Change %
PMCB100%
-1.18%
FATE - PMCB
33%
Poorly correlated
-6.00%
MBRX - PMCB
28%
Poorly correlated
-15.07%
BTAI - PMCB
28%
Poorly correlated
-4.01%
DTIL - PMCB
28%
Poorly correlated
-3.38%
ELVN - PMCB
27%
Poorly correlated
+3.48%
More